378 related articles for article (PubMed ID: 19638089)
1. Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring.
Xiao YL; Lin JK; Cheung TK; Wong NY; Hung IF; Wong BC; Peng S; Wang AJ; Chen MH
J Gastroenterol Hepatol; 2009 Jun; 24(6):1113-8. PubMed ID: 19638089
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
[TBL] [Abstract][Full Text] [Related]
3. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the different characteristics of sensed reflux events among different heartburn groups.
Schey R; Shapiro M; Navarro-Rodriguez T; Fass SS; Han B; Wendel C; Fass R
J Clin Gastroenterol; 2009 Sep; 43(8):699-704. PubMed ID: 18797407
[TBL] [Abstract][Full Text] [Related]
5. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring.
Conchillo JM; Schwartz MP; Selimah M; Samsom M; Sifrim D; Smout AJ
Dig Dis Sci; 2008 Jun; 53(6):1506-12. PubMed ID: 17934853
[TBL] [Abstract][Full Text] [Related]
6. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
Hershcovici T; Jha LK; Fass R
J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
[TBL] [Abstract][Full Text] [Related]
7. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
[TBL] [Abstract][Full Text] [Related]
8. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
9. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
[TBL] [Abstract][Full Text] [Related]
10. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
11. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
[TBL] [Abstract][Full Text] [Related]
12. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
13. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
Lee KJ; Kwon HC; Cheong JY; Cho SW
Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
16. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn.
Chu C; Du Q; Li C; Zhang L; Zhou X; Zuo F; Zhang Y; Li F; Xie G; Li Y
PLoS One; 2017; 12(4):e0175263. PubMed ID: 28384225
[TBL] [Abstract][Full Text] [Related]
18. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
Frazzoni M; Conigliaro R; Mirante VG; Melotti G
Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
[TBL] [Abstract][Full Text] [Related]
19. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
20. [Oesophageal acid exposure test in non-erosive gastroesophageal reflux disease and the diagnostic value of rabeprazole].
Fan YH; Lü B; Zhan LX; Zhang L
Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):475-7. PubMed ID: 17663823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
